Skip to content

Latest News

Serious constitutional crisis has arisen in Delhi, says CM Arvind Kejriwal

Serious constitutional crisis has arisen in Delhi, says CM Arvind Kejriwal

This problem stems from Delhi not enjoying full statehood and the real power lies with the central government, which is led by a different party, and “that other party does not want that the elected government (of Delhi) does its work”, he said during his address in the Delhi Assembly.

Read More

​ This problem stems from Delhi not enjoying full statehood and the real power lies with the central government, which is led by a different party, and “that other party does not want that the elected government (of Delhi) does its work”, he said during his address in the Delhi Assembly. This problem stems from Delhi not enjoying full statehood and the real power lies with the central government, which is led by a different party, and “that other party does not want that the elected government (of Delhi) does its work”, he said during his address in the Delhi Assembly.  Moneycontrol Latest News Read More  

This problem stems from Delhi not enjoying full statehood and the real power lies with the central government, which is led by a different party, and “that other party does not want that the elected government (of Delhi) does its work”, he said during his address in the Delhi Assembly.

Nifty pharma index nears all-time high, here are stocks signalling more upside

Nifty pharma index nears all-time high, here are stocks signalling more upside

With Nifty Pharma closing in on all-time high, more momentum-based trades can be expected in the short term in names such as Sun Pharma, Dr. Reddy#39;s and Cipla, say experts

Read More

​ With Nifty Pharma closing in on all-time high, more momentum-based trades can be expected in the short term in names such as Sun Pharma, Dr. Reddy#39;s and Cipla, say experts With Nifty Pharma closing in on all-time high, more momentum-based trades can be expected in the short term in names such as Sun Pharma, Dr. Reddy#39;s and Cipla, say experts  Moneycontrol Latest News Read More  

With Nifty Pharma closing in on all-time high, more momentum-based trades can be expected in the short term in names such as Sun Pharma, Dr. Reddy#39;s and Cipla, say experts

Moneycontrol Pro Panorama | When lowly earnings get a seat at the high table 

Moneycontrol Pro Panorama | When lowly earnings get a seat at the high table 

In today#39;s edition of Moneycontrol Pro Panorama: PM Modi reaches out to the Muslim world, Russian economy braves Western sanctions, markets ready for a high but investors must be cautious, US and China vie for Bangladesh#39;s attention putting India on backfoot, and more

Read More

​ In today#39;s edition of Moneycontrol Pro Panorama: PM Modi reaches out to the Muslim world, Russian economy braves Western sanctions, markets ready for a high but investors must be cautious, US and China vie for Bangladesh#39;s attention putting India on backfoot, and more In today#39;s edition of Moneycontrol Pro Panorama: PM Modi reaches out to the Muslim world, Russian economy braves Western sanctions, markets ready for a high but investors must be cautious, US and China vie for Bangladesh#39;s attention putting India on backfoot, and more  Moneycontrol Latest News Read More  

In today#39;s edition of Moneycontrol Pro Panorama: PM Modi reaches out to the Muslim world, Russian economy braves Western sanctions, markets ready for a high but investors must be cautious, US and China vie for Bangladesh#39;s attention putting India on backfoot, and more

Schaeffler India slips 4% after profit slumps 9.25% in Dec quarter

Schaeffler India slips 4% after profit slumps 9.25% in Dec quarter

The company#39;s revenue from operations grew by 4.5 percent to Rs 1,875 crore compared to the year-ago period.

Read More

​ The company#39;s revenue from operations grew by 4.5 percent to Rs 1,875 crore compared to the year-ago period. The company#39;s revenue from operations grew by 4.5 percent to Rs 1,875 crore compared to the year-ago period.  Moneycontrol Latest News Read More  

The company#39;s revenue from operations grew by 4.5 percent to Rs 1,875 crore compared to the year-ago period.

en_USEnglish
hi_INहिन्दी en_USEnglish